These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15471187)

  • 21. [Integrating HPV testing for primary screening?].
    Riethmuller D; Ramanah R; Pretet JL; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hovering on the threshold of change.
    Andrews J
    J Low Genit Tract Dis; 2015 Apr; 19(2):89-90. PubMed ID: 25574660
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the impact of adding HPV types to cervical cancer screening and triage tests.
    Schiffman M; Khan MJ; Solomon D; Herrero R; Wacholder S; Hildesheim A; Rodriguez AC; Bratti MC; Wheeler CM; Burk RD; ;
    J Natl Cancer Inst; 2005 Jan; 97(2):147-50. PubMed ID: 15657345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial quickly changed management of cervical abnormalities.
    Zielinski SL
    J Natl Cancer Inst; 2005 Apr; 97(7):479-80. PubMed ID: 15812071
    [No Abstract]   [Full Text] [Related]  

  • 25. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
    Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
    Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment.
    Bekkers RL; Meijer CJ; Massuger LF; Snijders PJ; Melchers WJ
    Gynecol Oncol; 2006 Mar; 100(3):451-4. PubMed ID: 16325896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular diagnostic techniques in gynaecologic cancer].
    Salvesen HB; Iversen OE; Tropé C
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3120-3. PubMed ID: 16299569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
    Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
    Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and typing of human papillomavirus nucleic acids in biological fluids.
    Coutlée F; Mayrand MH; Roger M; Franco EL
    Public Health Genomics; 2009; 12(5-6):308-18. PubMed ID: 19684443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The detection of cervical carcinoma].
    Acciotta M; Bertaglia A; Ferrari De Gaetani C
    Minerva Med; 1969 Jul; 60(55):2765-8. PubMed ID: 5794621
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of human viral pathogens: conventional versus molecular approaches.
    Wu MT; Garner OB
    MLO Med Lab Obs; 2014 Jul; 46(7):8, 10-2; quiz 14. PubMed ID: 25158395
    [No Abstract]   [Full Text] [Related]  

  • 34. Preface.
    Makowski GS
    Adv Clin Chem; 2017; 81():ix-x. PubMed ID: 28629593
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of molecular diagnostics on treatment pathways, outcomes, and cost. Introduction.
    Fine MJ
    Manag Care; 2010 Oct; 19(10 Suppl 4):1 p preceding table of contents. PubMed ID: 21128520
    [No Abstract]   [Full Text] [Related]  

  • 36. [Concerning a very rapid diagnostic method of presumption of cervical cancer].
    CAPELL
    Tokoginecol Pract; 1958 Dec; 17(167):598-601. PubMed ID: 13625306
    [No Abstract]   [Full Text] [Related]  

  • 37. [Carcinoma of the portio; diagnostic methodology].
    PEREGO A
    Ann Ostet Ginecol; 1958 Aug; 80(8):711-75. PubMed ID: 13661732
    [No Abstract]   [Full Text] [Related]  

  • 38. The elephant in the room: contamination control in molecular testing.
    Brunstein J
    MLO Med Lab Obs; 2014 Jul; 46(7):44, 46. PubMed ID: 25158405
    [No Abstract]   [Full Text] [Related]  

  • 39. Histopathology meets molecular pathology.
    Regezi JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):589-90. PubMed ID: 11740470
    [No Abstract]   [Full Text] [Related]  

  • 40. Cervical disease screening and detection: emerging techniques in molecular diagnostic assays.
    Rosenthal DL
    MLO Med Lab Obs; 2004 Sep; 36(9):10-1, 14-6; quiz 18-9. PubMed ID: 15471187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.